Autism Spectrum Disorder Trial, Recruiting (NCT05512637)

Autism Spectrum Disorder Trial, Recruiting NCT05512637 Sponsor: University Hospital, Montpellier Condition: Autism Spectrum Disorder

Printed from Voxsanity (voxsanity.com.au) — NCT05512637 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Autism Spectrum Disorder

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

You are a brother or sister (including step-siblings) of the main study participant
You are between 2 and 16 years old
You live in the Occitanie region of France
Your parents have been informed about the trial and have agreed to take part
You are covered by French social security
Either your first screening (Step 1) came back positive, or your parents have concerns about your child's development (this applies to Step 2 of the trial)
Your parents have signed a consent form agreeing to participate (Step 2)

Who may not be able to join:

Your parents or you (the child) do not want to take part in the trial
You are an adopted sibling rather than a biological or step-sibling
You or your family do not speak French

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 21 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Véronique GONNIER, Dr, University Hospital, Montpellier

Phone: 467330986

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT05512637

Sponsor: University Hospital, Montpellier

Phase: Not Applicable

Status: Recruiting

Condition: Autism Spectrum Disorder

Trial contact: 467330986

More information: https://clinicaltrials.gov/study/NCT05512637

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

You are a brother or sister (including step-siblings) of the main study participant
You are between 2 and 16 years old
You live in the Occitanie region of France
Your parents have been informed about the trial and have agreed to take part
You are covered by French social security
Either your first screening (Step 1) came back positive, or your parents have concerns about your child's development (this applies to Step 2 of the trial)
Your parents have signed a consent form agreeing to participate (Step 2)

Who may not be able to join:

Your parents or you (the child) do not want to take part in the trial
You are an adopted sibling rather than a biological or step-sibling
You or your family do not speak French

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 21 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

University Hospital, Montpellier

Registry

ClinicalTrials.gov

Start date

28 November 2023

Est. completion

1 November 2026

Where this trial is recruiting

🇫🇷 France

Primary endpoints

Percentage of family participation

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 21 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov